v3.26.1
Stock-based Compensation - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Mar. 14, 2025
Mar. 13, 2025
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Aggregate inducement awards outstanding     4,392,430       4,392,430    
Number of options, outstanding     6,624,927       6,624,927    
Common stock, shares outstanding     134,365,950       134,365,950   98,776,265
Stock-based compensation expense recognized     $ 9,639   $ 5,253   $ 16,771 $ 8,679  
Nominal amount of expense in relation to ESPP recognized       $ 276   $ 186      
Accrued expenses     37,222       37,222   $ 20,446
Unrecognized stock-based compensation expense related to unvested options granted     $ 38,100       $ 38,100    
Weighted average period for recognition of unvested options granted             3 years 2 months 12 days    
Employee Stock [Member]                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Weighted average period for recognition of unvested options granted             2 years 10 months 24 days    
RSUs                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Number of other than options, outstanding     60,000       60,000    
Number of shares, granted             2,954,895    
Number of shares, vested             462,361    
Stock-based compensation expense recognized     $ 7,000   3,600   $ 11,600 5,400  
Unrecognized stock-based compensation expense related to unvested options granted     67,400       $ 67,400    
Directors' Deferred Share Unit Plan                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Number of shares, vested             199,026    
Stock-based compensation expense recognized     5,200   200   $ 6,200 200  
Accrued expenses     $ 8,900       $ 8,900    
Employee Stock Option                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Number of options, outstanding     4,013,430       4,013,430    
Number of shares, granted             1,251,480    
Stock-based compensation expense recognized     $ 2,600   $ 1,600   $ 5,000 $ 3,200  
Nominal amount of expense in relation to ESPP recognized             $ 200    
Nominal amount of expense in relation to ESPP             33,787    
Performance shares units                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Vesting percentage             200.00%    
Number of other than options, outstanding     319,000       319,000    
Number of shares, granted             34,500    
Vesting period             36 months    
Requisite service period             36 months    
Performance shares units | Tranche One                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Number of shares, granted             319,500    
Performance shares units | Tranche Two                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Number of shares, granted             639,000    
MindMed Stock Option Plan                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Vesting percentage   15.00%         15.00%    
Number of shares, granted 0                
Vesting rights, description             Prior to March 14, 2025, the Company was authorized to issue a number of equity awards equal to 15% of the Company’s issued and outstanding Common Shares under the terms of the 2020 Option Plan, together with Common Shares that were issuable pursuant to outstanding awards or grants under any other compensation or incentive mechanism involving the issuance or potential issuance of Common Shares, including the MindMed Performance and Restricted Share Unit Plan (“2020 PRSU Plan”) and ESPP.    
MindMed Stock Option Plan | Maximum                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Common stock, shares outstanding         9,318,090     9,318,090  
MindMed Stock Option Plan | Restricted Share Unit Awards and Performance Share Unit Awards                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Common stock, shares outstanding         5,817,111     5,817,111  
MindMed Stock Option Plan | Employee Stock Option                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Common stock, shares outstanding         3,500,979     3,500,979  
2025 Equity Incentive Plan                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Common shares reserved for future issuance     5,000,000   4,500,000   5,000,000 4,500,000  
2025 Equity Incentive Plan | RSUs                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Number of shares, granted             2,315,895    
2025 Equity Incentive Plan | Employee Stock Option                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Number of shares, granted             536,495    
2025 Equity Incentive Plan | Performance shares units                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Number of shares, granted             285,000    
2026 Inducement Plan                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Common shares reserved for future issuance     3,000,000       3,000,000    
Number of shares, granted             0    
PRSU Plan                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Vesting percentage             15.00%    
Number of shares, granted 0